Home » Headlines » Currently Reading:

Morning Headlines 10/19/17

October 18, 2017 Headlines No Comments

Tom Marino, Drug Czar Nominee, Withdraws in Latest Setback for Trump’s Opioid Fight

A 60 Minutes and Washington Post investigative report exposes a multi-year effort by drug distributor lobbyists to push an industry-friendly bill through Congress that ultimately undercut the DEA’s drug distribution enforcement options at the height of the opioid epidemic. Rep. Tom Marino (R-PA), President Trump’s Drug Czar nominee, withdrew his name from consideration after the report called him the “chief advocate of the law that hobbled the DEA.”

IBM shares up after earnings beat

IBM reports Q3 results: $19.15 billion in revenue and $3.3o adjusted EPS, beating analyst expectations on both, but marking its 22nd straight quarter without revenue growth. The company’s AI business unit brought in $4.4 billion in revenue, up 4 percent.

Virtual Therapists Help Veterans Open Up About PTSD

Wired covers the use of teletherapy in the treatment of PTSD among veterans.

White House says Trump opposes Senate’s bipartisan Obamacare deal

In a reversal, the White House now says it opposes the bipartisan deal drafted by Senators Lamar Alexander (R-TN) and Patrick Murray (D-WA) that would stabilize ACA marketplaces and restore the payment of cost-sharing subsidies.

View/Print Text Only View/Print Text Only

HIStalk Featured Sponsors


Subscribe to Updates



Text Ads

Report News and Rumors

No title

Anonymous online form
Rumor line: 801.HIT.NEWS



Founding Sponsors


Platinum Sponsors
























































Gold Sponsors

















Reader Comments

  • FRANK POGGIO: Shows to go ya...answering black and white Jeopardy questions is a far cry from the massive grey area of medicine/pharma...
  • Number Cruncher: You are right AC. The cost is seriously underestimated here. Just looking at the numbers - $1 B for 5 years = $200 M ...
  • Abraham Van Helsing: Re Theranos. Will be interesting to follow the saga. As I and others had noted going back 2+ years, something was obvi...
  • Prof. Moriarty: Re: Watson pull out. I've not been directly involved with this product, but from its beginning I have always seen Watso...
  • mih: Of course they can, and for much much cheaper. But why would they do it? Existing arrangement works for everyone in the ...
  • Andrew M. Harrison: Thanks for (actually) reading our paper. I enjoyed the story of your friend, as well as the translation of numbers to em...
  • Mike: I would love to see this type of discussion around Blockchain. It is being hyped heavily currently. Yet, I wonder how we...
  • Brian Too: Just slightly off-topic, but I recently heard an interesting downtime rule-of-thumb: Every hour of downtime requires 2 ...
  • James E Thompson: AI in particular isn't disruptive until it can offer an effective alternative against which a go/no-go decision makes se...
  • Former Newspaper Guy: I applaud your attention to grammar and style. In high school, I worked for the local newspaper in the sports department...

RSS Industry Events

  • An error has occurred, which probably means the feed is down. Try again later.

Sponsor Quick Links